vs
Side-by-side financial comparison of AMERICAN SUPERCONDUCTOR CORP (AMSC) and ImmunityBio, Inc. (IBRX). Click either name above to swap in a different company.
AMERICAN SUPERCONDUCTOR CORP is the larger business by last-quarter revenue ($74.5M vs $38.3M, roughly 1.9× ImmunityBio, Inc.). AMERICAN SUPERCONDUCTOR CORP runs the higher net margin — 158.1% vs -161.8%, a 319.9% gap on every dollar of revenue. On growth, ImmunityBio, Inc. posted the faster year-over-year revenue change (407.0% vs 21.4%). AMERICAN SUPERCONDUCTOR CORP produced more free cash flow last quarter ($2.4M vs $-71.3M).
Anglo American plc is a British multinational mining company with headquarters in London, England. It is the world's largest producer of platinum, representing approximately 40 percent of global output, as well as being a major producer of diamonds, copper, nickel, iron ore, polyhalite and steelmaking coal. The company has operations in Africa, Asia, Australia, Europe, North America and South America.
ImmunityBio, Inc. is a clinical-stage biotechnology company focused on developing next-generation immunotherapies and vaccine candidates targeting multiple cancer types and infectious diseases. It operates mainly in the U.S. market, with core R&D segments including cell therapy, antibody therapeutics, and targeted vaccine platforms designed to enhance patient treatment outcomes.
AMSC vs IBRX — Head-to-Head
Income Statement — Q3 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $74.5M | $38.3M |
| Net Profit | $117.8M | $-61.9M |
| Gross Margin | 30.7% | 99.0% |
| Operating Margin | 4.5% | -169.0% |
| Net Margin | 158.1% | -161.8% |
| Revenue YoY | 21.4% | 407.0% |
| Net Profit YoY | 4679.1% | -4.7% |
| EPS (diluted) | $2.62 | $-0.06 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $74.5M | $38.3M | ||
| Q3 25 | $65.9M | $32.1M | ||
| Q2 25 | $72.4M | $26.4M | ||
| Q1 25 | $66.7M | $16.5M | ||
| Q4 24 | $61.4M | $7.6M | ||
| Q3 24 | $54.5M | $6.1M | ||
| Q2 24 | $40.3M | — | ||
| Q1 24 | $42.0M | — |
| Q4 25 | $117.8M | $-61.9M | ||
| Q3 25 | $4.8M | $-67.3M | ||
| Q2 25 | $6.7M | $-92.6M | ||
| Q1 25 | $1.2M | $-129.6M | ||
| Q4 24 | $2.5M | $-59.2M | ||
| Q3 24 | $4.9M | $-85.7M | ||
| Q2 24 | $-2.5M | — | ||
| Q1 24 | $-1.6M | — |
| Q4 25 | 30.7% | 99.0% | ||
| Q3 25 | 31.0% | 99.4% | ||
| Q2 25 | 33.8% | 99.5% | ||
| Q1 25 | 26.5% | 99.6% | ||
| Q4 24 | 26.6% | — | ||
| Q3 24 | 28.7% | — | ||
| Q2 24 | 30.3% | — | ||
| Q1 24 | 24.8% | — |
| Q4 25 | 4.5% | -169.0% | ||
| Q3 25 | 4.5% | -173.5% | ||
| Q2 25 | 7.8% | -269.8% | ||
| Q1 25 | 2.5% | -390.1% | ||
| Q4 24 | 2.1% | -919.0% | ||
| Q3 24 | -1.4% | -1314.3% | ||
| Q2 24 | -8.2% | — | ||
| Q1 24 | -5.3% | — |
| Q4 25 | 158.1% | -161.8% | ||
| Q3 25 | 7.2% | -209.8% | ||
| Q2 25 | 9.3% | -350.3% | ||
| Q1 25 | 1.8% | -784.9% | ||
| Q4 24 | 4.0% | -783.4% | ||
| Q3 24 | 9.0% | -1404.0% | ||
| Q2 24 | -6.3% | — | ||
| Q1 24 | -3.8% | — |
| Q4 25 | $2.62 | $-0.06 | ||
| Q3 25 | $0.11 | $-0.07 | ||
| Q2 25 | $0.17 | $-0.10 | ||
| Q1 25 | $0.04 | $-0.15 | ||
| Q4 24 | $0.06 | $-0.08 | ||
| Q3 24 | $0.13 | $-0.14 | ||
| Q2 24 | $-0.07 | — | ||
| Q1 24 | $-0.03 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $141.1M | $242.8M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $536.8M | $-500.5M |
| Total Assets | $719.5M | $501.9M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $141.1M | $242.8M | ||
| Q3 25 | $212.9M | $257.8M | ||
| Q2 25 | $207.9M | $153.7M | ||
| Q1 25 | $79.5M | $61.6M | ||
| Q4 24 | $75.2M | $149.8M | ||
| Q3 24 | $72.1M | $130.4M | ||
| Q2 24 | $93.5M | — | ||
| Q1 24 | $90.5M | — |
| Q4 25 | $536.8M | $-500.5M | ||
| Q3 25 | $342.2M | $-524.3M | ||
| Q2 25 | $333.1M | $-570.7M | ||
| Q1 25 | $197.1M | $-591.4M | ||
| Q4 24 | $192.7M | $-489.1M | ||
| Q3 24 | $187.0M | $-745.1M | ||
| Q2 24 | $143.3M | — | ||
| Q1 24 | $144.6M | — |
| Q4 25 | $719.5M | $501.9M | ||
| Q3 25 | $445.6M | $519.0M | ||
| Q2 25 | $452.8M | $402.1M | ||
| Q1 25 | $310.5M | $303.8M | ||
| Q4 24 | $310.3M | $382.9M | ||
| Q3 24 | $298.4M | $364.6M | ||
| Q2 24 | $240.1M | — | ||
| Q1 24 | $232.8M | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $3.2M | $-70.4M |
| Free Cash FlowOCF − Capex | $2.4M | $-71.3M |
| FCF MarginFCF / Revenue | 3.2% | -186.2% |
| Capex IntensityCapex / Revenue | 1.2% | 2.4% |
| Cash ConversionOCF / Net Profit | 0.03× | — |
| TTM Free Cash FlowTrailing 4 quarters | $16.0M | $-308.8M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $3.2M | $-70.4M | ||
| Q3 25 | $6.5M | $-68.9M | ||
| Q2 25 | $4.1M | $-79.7M | ||
| Q1 25 | $6.3M | $-85.9M | ||
| Q4 24 | $5.9M | $-85.1M | ||
| Q3 24 | $12.7M | $-98.8M | ||
| Q2 24 | $3.4M | — | ||
| Q1 24 | $2.2M | — |
| Q4 25 | $2.4M | $-71.3M | ||
| Q3 25 | $5.1M | $-69.6M | ||
| Q2 25 | $3.3M | $-80.8M | ||
| Q1 25 | $5.3M | $-87.0M | ||
| Q4 24 | $5.3M | $-87.3M | ||
| Q3 24 | $12.1M | $-101.6M | ||
| Q2 24 | $3.1M | — | ||
| Q1 24 | $1.9M | — |
| Q4 25 | 3.2% | -186.2% | ||
| Q3 25 | 7.7% | -217.2% | ||
| Q2 25 | 4.6% | -305.9% | ||
| Q1 25 | 7.9% | -526.9% | ||
| Q4 24 | 8.7% | -1155.4% | ||
| Q3 24 | 22.3% | -1663.2% | ||
| Q2 24 | 7.8% | — | ||
| Q1 24 | 4.6% | — |
| Q4 25 | 1.2% | 2.4% | ||
| Q3 25 | 2.1% | 2.3% | ||
| Q2 25 | 1.1% | 4.1% | ||
| Q1 25 | 1.6% | 6.8% | ||
| Q4 24 | 0.9% | 28.0% | ||
| Q3 24 | 1.1% | 45.7% | ||
| Q2 24 | 0.7% | — | ||
| Q1 24 | 0.7% | — |
| Q4 25 | 0.03× | — | ||
| Q3 25 | 1.37× | — | ||
| Q2 25 | 0.61× | — | ||
| Q1 25 | 5.22× | — | ||
| Q4 24 | 2.38× | — | ||
| Q3 24 | 2.60× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
AMSC
| Equipment And Systems | $56.0M | 75% |
| Megatran | $14.1M | 19% |
| Comtrafo Industria De Transformadores Eletricos SA | $4.6M | 6% |
IBRX
Segment breakdown not available.
